Company Details
  • Conbott Pharmtech Co.,Ltd.

  •  [Zhejiang,China]
  • Business Type:Manufacturer
  • Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
  • Exporter:71% - 80%
  • Certs:COS, ISO9001, ISO14010, FDA
  • Description:1256963-02-6,CAS 1256963-02-6,CAS NO 1256963-02-6
Conbott Pharmtech Co.,Ltd. 1256963-02-6,CAS 1256963-02-6,CAS NO 1256963-02-6
Home > Products > Inhibitors > CDK Inhibitor > LEE011 CDK4/6 Inhibitor CAS 1256963-02-6
Title
  • Title
  • All
Online Service
http://www.conbottpharm.comScan to visit

LEE011 CDK4/6 Inhibitor CAS 1256963-02-6

Share to:  
    Payment Type: T/T,L/C
    Min. Order: 1 Gram

Basic Info

Model No.1256963-02-6

BrandConbottpharm

Additional Info

PackagingAs required

ProductivityCustomized

TransportationOcean,Air

Place of OriginChina

Supply AbilityCommercial

CertificateDocuments Support

Payment TypeT/T,L/C

Product Description


Ribociclib CAS 1256963-02-6, also known as LEE011 and CDK4/6 inhibitor , is an orally available cyclin-dependent kinase (CDK) inhibitor. Ribociclib also specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation. We can offer high purity, premium quality, secure, stable and reliable LEE011 to our customers. Manufacture CDK4/6 inhibitor CAS NO 1256963-02-6 from precise formulation raw material using latest technology and advanced equipment. Ribociclib 1256963-02-6 is guarantee 100% genuine high purity powder. Customers can choose at ease.


Thera. Category: CDK4/6 inhibitor

Cas No.: 1256963-02-6

Synonym: LEE011;CDK4/6 inhibitor;CDK4 inhibitor;CDK4-IN-1;Ribociclib;4-(5-Chloro-3-isopropyl-1H-pyrazol-4-yl)-N-(5-(4-(dimethylamino)piperidin-1-yl)pyridin-2-yl)pyrimidin-2-amine;Ribociclib(LEE011);Ribociclib(Lee011 & CDK 4/6 inhibitor)

1256963-02-6

Molecular Formula:C22H29ClN8

Molecular Weight:440.97226

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Ribociclib is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity.

Product Categories : Inhibitors > CDK Inhibitor

Product Images
  • LEE011 CDK4/6 Inhibitor CAS 1256963-02-6
Email to this supplier
  • *Subject:
  • *Messages:
    Your message must be between 20-8000 characters
Copyright © 2024 Conbott Pharmtech Co.,Ltd. All rights reserved.
Communicate with Supplier?Supplier
Tommy Mr. Tommy
What can I do for you?